CT032
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CT032, covering 2023-04-14 to 2023-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma [Phase 1, Phase 2]